Actual problems of stenting using in critical limb ischemia (cli) treatment
Abstract
Critical limb ischemia is a life-threatening disease that often results in partial disability or death. One of the ways in optimizing its endovascular treatment is the stents using. The current review presents results of several meta-analyses testing of different stent types different segments of the arterial bloodstream in lower limbs. Using of drug-eluting stents in the femoral-popliteal segment improves the treatment results of critical ischemia in lower limbs compared with other methods of revascularization. Currently, in case of short local injuries, drug-eluting covered stents implementation is recommended at the segment of lower leg.
Downloads
References
Zatevahin II, Shipovskij VN, Zolkin VN. Ballonnaja angioplastika pri ishemii nizhnih konechnostej (Rus). M.: Medicina, 2004:83.
Antonopoulos CN, Mylonas SN, Moulakakis KG et al. A network meta-analysis of randomized controlled trials comparing treatment modalities for de novo superficial femoral artery occlusive lesions. J. Vasc. Surg. 2017;65(1):234-45. e11. doi: 10.1016/j. jvs.2016.08.095. Epub 2016 Nov 16.
Koifman E, Lipinski MJ, Buchanan K et al. Comparison of treatment strategies for femoro-popliteal disease: A network meta-analysis. Catheter Cardiovasc. Interv. 2018 Jan 14. doi: 10.1002/ccd.27484.
Antoniou GA, Georgakarakos EI, Antoniou SA, Georgiadis GS. Does endovascular treatment of infra-inguinal arterial disease with drug-eluting stents offer better results than angioplasty with or without bare metal stents? Interact. Cardiovasc. Thorac Surg. 2014;19(2):282-5. doi: 10.1093/icvts/ivu093. Epub 2014 Apr 11.
Kayssi A, Al-Atassi T, Oreopoulos G et al. Drug-eluting balloon angioplasty versus uncoated balloon angioplasty for peripheral arterial disease of the lower limbs. Cochrane Database Syst. Rev. 2016;(8):CD011319. doi: 10.1002/14651858.CD011319.pub2. Review.
Jongsma H, Bekken JA, de Vries JP, Verhagen HJ, Fioole B. Drug-eluting balloon angioplasty versus uncoated balloon angioplasty in patients with fem- oropopliteal arterial occlusive disease. J. Vasc. Surg. 2016;64(5):1503-14. doi: 10.1016/jjvs.2016.05.084. Epub 2016 Jul 29. Review.
Trombert D, Caradu C, Brizzi V et al. Evidence for the use of drug eluting stents in below-the-knee lesions. J. Cardiovasc. Surg. (Torino). 2015;56(1):67-71. Epub 2014 Nov 27. Review.
Lu H, Guo P. Plasma heparin cofactor II activity correlates with the incidence of in-stent restenosis after the intervention of arteriosclerosis obliterans in lower extremity. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2015;40(2):177-81. doi: 10.11817/j.issn.1672- 7347.2015.02.010.
Mosquera Arochena NJ. Drug-eluting stents remain the golden standard for below-the-knee occlusive disease. J. Cardiovasc. Surg. (Torino). 2016;57(5):677- 82. Epub 2016 Jun 22. Review.
Caradu C, Brizzi V, Auque H, Midy D, Ducasse E. Sense and nonsense of bare metal stents below the knee. J. Cardiovasc. Surg. (Torino). 2016;57(5):653-66. Epub 2016 May 13. Review. PubMed PMID: 27177357.
Tartari S, Zattoni L, Rizzati R et al. Subintimal angioplasty as the first-choice revascularization technique for infrainguinal arterial occlusions in patients with critical limb ischemia. Ann. Vasc. Surg. 2007;21(6):819-28.
Yang X, Lu X, Ye K et al. Systematic review of primary stenting for arteriosclerotic occlusion in be- low-the-knee arteries. Zhonghua Yi Xue Za Zhi. 2014;94(11):821-7. Review.
Van den Berg JC. In-stent restenosis management: the best is yet to come. J. Cardiovasc. Surg (Torino). 2017;58(4):508-17. doi: 10.23736/S0021-9509.17.09953-0. Epub 2017 Mar 20.
Vraux H, Bertoncello N. Subintimal angioplasty of tibial vessel occlusions in critical limb ischaemia: a good opportunity? Eur. J. Vasc. Endovasc. Surg. 2006;32(6):663-7. Epub 2006 Aug 24. PubMed PMID: 16935010.
Werner M. Drug eluting stents and modern stent technologies for in-stent restenosis. J. Cardiovasc. Surg . (Torino). 2017;58(4):497-500. doi: 10.23736/S0021- 9509.17.09955-4. Epub 2017 Apr 4. Review.
This work is licensed under a Creative Commons Attribution 4.0 International License.
